These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 39186984)
1. Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease. Peng P; Feng T; Yang X; Ding R; Wang J; Chen P; Guo Y; Li P J Control Release; 2024 Oct; 374():538-549. PubMed ID: 39186984 [TBL] [Abstract][Full Text] [Related]
2. Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H Yang J; Ge S; Tan S; Liu H; Yang M; Liu W; Zhang K; Zhang Z; Liu J; Shi J; Wang ZH; Li J J Control Release; 2024 Oct; 374():140-153. PubMed ID: 39117113 [TBL] [Abstract][Full Text] [Related]
3. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Li M; Liu N; Zhu J; Wu Y; Niu L; Liu Y; Chen L; Bai B; Miao Y; Yang Y; Chen Q Biomaterials; 2024 Sep; 309():122584. PubMed ID: 38735180 [TBL] [Abstract][Full Text] [Related]
4. Both viable Li Z; Peng C; Sun Y; Zhang T; Feng C; Zhang W; Huang T; Yao G; Zhang H; He Q Microbiol Spectr; 2024 Jun; 12(6):e0350923. PubMed ID: 38647334 [TBL] [Abstract][Full Text] [Related]
5. Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease. Dong F; Hao L; Wang L; Huang Y J Control Release; 2024 Sep; 373():749-765. PubMed ID: 39084465 [TBL] [Abstract][Full Text] [Related]
6. Breaking barriers: bacterial-microalgae symbiotic systems as a probiotic delivery system. Huang H; Liu X; Lang Y; Cui J; Zhong D; Zhou M J Nanobiotechnology; 2024 Jun; 22(1):371. PubMed ID: 38918805 [TBL] [Abstract][Full Text] [Related]
7. Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice. Zhu Y; Xu Y; Wang X; Rao L; Yan X; Gao R; Shen T; Zhou Y; Kong C; Zhou L Front Cell Infect Microbiol; 2022; 12():886061. PubMed ID: 35782138 [TBL] [Abstract][Full Text] [Related]
8. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease. Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877 [TBL] [Abstract][Full Text] [Related]
9. Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic Olivo-Martínez Y; Martínez-Ruiz S; Cordero-Alday C; Bosch M; Badia J; Baldoma L Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791376 [TBL] [Abstract][Full Text] [Related]
10. Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota. Wang W; Xing W; Wei S; Gao Q; Wei X; Shi L; Kong Y; Su Z J Microbiol Biotechnol; 2019 Sep; 29(9):1478-1487. PubMed ID: 30270604 [TBL] [Abstract][Full Text] [Related]
11. Tilapia head glycolipids reduce inflammation by regulating the gut microbiota in dextran sulphate sodium-induced colitis mice. Gu Z; Zhu Y; Jiang S; Xia G; Li C; Zhang X; Zhang J; Shen X Food Funct; 2020 Apr; 11(4):3245-3255. PubMed ID: 32219260 [TBL] [Abstract][Full Text] [Related]
13. The Alleviation of Gut Microbiota-Induced Depression and Colitis in Mice by Anti-Inflammatory Probiotics NK151, NK173, and NK175. Yoo JW; Shin YJ; Ma X; Son YH; Jang HM; Lee CK; Kim DH Nutrients; 2022 May; 14(10):. PubMed ID: 35631220 [TBL] [Abstract][Full Text] [Related]
14. Lactobacillus rhamnosus GG coating with nanocomposite ameliorates intestinal inflammation. Zhai Z; Wang X; Qian Z; Wang A; Zhao W; Xiong J; Wang J; Wang Y; Cao H Biomed Pharmacother; 2024 Sep; 178():117197. PubMed ID: 39084077 [TBL] [Abstract][Full Text] [Related]
15. Lactobacillus rhamnosus KBL2290 Ameliorates Gut Inflammation in a Mouse Model of Dextran Sulfate Sodium-Induced Colitis. Kim WK; Min SG; Kwon H; Park S; Jo MJ; Ko G J Microbiol; 2023 Jul; 61(7):673-682. PubMed ID: 37314676 [TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal Microenvironment Responsive Nanoencapsulation of Probiotics and Drugs for Synergistic Therapy of Intestinal Diseases. Peng P; Feng T; Yang X; Nie C; Yu L; Ding R; Zhou Q; Jiang X; Li P ACS Nano; 2023 Aug; 17(15):14718-14730. PubMed ID: 37490035 [TBL] [Abstract][Full Text] [Related]
18. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951 [TBL] [Abstract][Full Text] [Related]
19. Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs. Algieri F; Garrido-Mesa J; Vezza T; Rodríguez-Sojo MJ; Rodríguez-Cabezas ME; Olivares M; García F; Gálvez J; Morón R; Rodríguez-Nogales A Eur J Nutr; 2021 Aug; 60(5):2537-2551. PubMed ID: 33216193 [TBL] [Abstract][Full Text] [Related]
20. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]